Marc Mazur

Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA.

Headquartered in San Francisco with additional offices in New York City, Minneapolis, Chicago and Boston, ThinkEquity Partners is a broker/dealer. The firm offers targeted research and investment banking services for institutional investors and corporate clients. They specialize in identifying, analyzing and understanding the technological, macroeconomic and cultural trends that impact key growth verticals, with a particular concentration on healthcare, technology, media/education and business/consumer services. The firm starts with a top-down analysis approach and then allocates resources based on a long-range research roadmap.

DeVilbiss Healthcare LLC designs, manufactures and markets respiratory medical products. It offers continuous positive airway pressure (CPAP) therapy and mask, sleep therapy management, sleep diagnostics, compressor nebulizers, professional ears, nose and tongue products, home suction therapy, oxygen concentrator, and pulse oximetry. The company was founded by Allen DeVilbiss in 1888 and is headquartered in Somerset, PA.

Brevan Howard U.S. Asset Management LLP is a hedge fund company located in New York City. They are a subsidiary of Brevan Howard Asset Management LLP in London.

Tsinghua Venture Capital Co. Ltd. (THVC) is the venture capital arm of Tsing Capital Co. Ltd., itself a subsidiary of Tsinghua Holdings Co. Ltd., which is wholly-owned by Tsinghua University in Beijing, a leading science, technology and engineering educational institution in China. A public institution, Tsinghua University is known for dynamic research commercialization and startup incubation activities. Tsinghua Holdings is the university's investment arm and operates as an exclusive platform for science and technology development, research commercialization, startup incubation and international business cooperation. Located in Beijing and established in 2000, THVC is a leading Chinese venture capital firm which manages international venture capital funds. Tsing Capital manages a series of SRI funds and the China Environment Funds, focused on clean technology.